Daily news email for August 23, 2012 | Click here for updated news
SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.
Manage projects more efficiently. Try PlanIt free for 15 days.
Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.
Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month
Use PlanIt as your next deal room! Click here to learn more.
|
b3c newswire
ZZ Biotech Initiates Phase 1 Study with 3K3A-APC for the Treatment of Acute Ischemic Stroke
AiCuris Promising Drugs Against Herpes Simplex (AIC316) and Human Cytomegalovirus (Letermovir, ...
CEVEC Licenses its Proprietary Human Cell Lines to Paragon Bioservices, Inc.
Cambridge Research Biochemicals Signs Deal with LI-COR Biosciences for Infrared Dye Labelled ...
2. Laupheimer Zelltage Attracts Top Scientists to Discuss Recent Advances in Biomanufacturing
|
BioSpace
Potency of Statins Linked to Muscle Side Effects, University of California, San Diego (UCSD) Study
Green Tea Compound Shows Promise for Tackling Cancer, University of Strathclyde Study
Cipla Ltd. Partners Aspen Pharmacare Ltd. for Australia Foray
Key to Burning Fat Faster Discovered, University of Copenhagen Study
Prostate Cancer: 6 Things Men Should Know About Tomatoes, Fish Oil, Vitamin Supplements, Testosterone, PSA Tests, Fred Hutchinson Cancer Research Center Study
|
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)
NIH Translational Center Should Raise All Boats, BIO Says
Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update
Biotechnology to be 21st-century industry: Life Tech CEO
|
Burrill Report
The September 2012 Issue of The Burrill Report
Elan to Shed Drug Discovery Unit
RNA Therapeutics in the Dealmaking Spotlight
Pfizer's Animal Health Unit Zoetis Files IPO
Inching Closer to a Pill for Men
|
CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend
New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising
Technology companies adapt interactive video concepts for clinical trial informed consent
CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases
New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
|
Clinical Trials - Business Wire
BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter Fiscal Year 2012
Research and Markets: Alpha - Antitrypsin Deficiency Global Clinical Trials Review, H2, 2012
Research and Markets: Uterine Fibroids Global Clinical Trials Review, H2, 2012
Research and Markets: Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2012
Penumbra Inc. Launches New 5MAX Reperfusion Catheter for Clot Removal in Patients with Acute Ischemic Stroke
|
Clinical Trials - PR Newswire
Biodesix Announces New VeriStrat® Data to be Presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology
Star Scientific's Rock Creek Subsidiary Enrolls First Alzheimer's Study Patient at Roskamp Institute
Elderly Kids: Alarming Number of US Children Affected by Adult-Onset Diseases
Canary Foundation announces $8.5 million in gifts to advance vital cancer early detection studies
Long Island Plastic Surgical Group President Kaveh Alizadeh, MD, MSc, FACS Featured In ASPS Plastic Surgery Update Video
|
CNN Top Stories
He's got lowest voice in the world
Hubby: Monogamy kills marriage
Inside look at a Chicago trauma unit
Rodney King's death ruled a drowning
John Lennon's killer denied parole
|
New York Times- Pharmaceuticals
Clues to Fighting Cancer Are Found in the Genes of Yeast
Get Antibiotics Off the Farm
Amgen, Citing Weak Results, Halts Study of a Cancer Drug
Pfizer Animal Health Unit Files for I.P.O.
Beware the Nocebo Effect
|
OnBioVC
Stemgent, Inc.: Series C $6.3M
Genalyte, Inc.: Series A $11.8M
Relievant Medsystems, Inc.: Series D $30M
ImaginAb, Inc.: Series A $12.5M
BiO2 Medical, Inc.: Series B $13.7M
|
Outsourcing-Pharma
Changes to EU clinical trial laws will mean fairer playing field, says Clinipace
Wockhardt targets CMO space for diversification
Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles
Home visits = regulatory thumbs up ResearchNurses.co thinks so
Home visits are the key to patient retention, says ResearchNurses.co
|
